Arginine as an Exacerbating Factor for Glomerulonephritis in Rats Fed a Methionine-threonine-supplemented Low Casein Diet

Bioscience, Biotechnology and Biochemistry

Volumn 65, Issue 5, 2001, Pages 1155-1162

  Nihei, Takeshi ^a   Arai, Katsuhiko ^a   Miura, Yutaka ^a   Yagasaki, Kazumi ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

L arginine; L NG nitroarginine methyl ester; Nephritis; Proteinuria

Indexed keywords

ARGININE; CASEIN; ENZYME INHIBITOR; METHIONINE; N(G) NITROARGININE METHYL ESTER; THREONINE;

ANIMAL; ARTICLE; BLOOD; DRUG ANTAGONISM; GLOMERULONEPHRITIS; MALE; PATHOPHYSIOLOGY; PROTEIN INTAKE; RAT; UREA NITROGEN BLOOD LEVEL; WISTAR RAT;

ANIMALS; ARGININE; BLOOD UREA NITROGEN; CASEINS; DIETARY PROTEINS; ENZYME INHIBITORS; GLOMERULONEPHRITIS; MALE; METHIONINE; NG-NITROARGININE METHYL ESTER; RATS; RATS, WISTAR; THREONINE;

EID: 0035351315     PISSN: 09168451     EISSN: None     Source Type: Journal    
DOI: 10.1271/bbb.65.1155     Document Type: Article

References (40)

1. Robbins, S. L., Cotran, R. C., and Kumar, V., Glomerular diseases. In "Pathological basis of disease, 3rd edition", eds. Robbins, S. L., Cotran, R. C. and Kumar, V., W. B. Saunders Co., Philadelphia, pp. 1002-1026 (1984).
2. Morel-Maroger, S. L., Killen, P. D., Chi, E., and Striker, G. E., The composition of glomerulosclerosis. 1. Studies in focal sclerosis, crescentic glomerulonephritis, and membranoproliferative glomerulonephritis. Lab. Invest., 51, 181-192 (1984)
3. Floege, J., Alpers, C. E., Burns, M. W., Pritzl, P., Gordon, K., Couser, W. G., and Johnson, R. J., Glomerular cells, extracellular matrix accumulation, and the development of glomerulosclerosis in the remnant kidney model. Lab. Invest., 66, 485-497 (1992).
4. Schnaper, H. W., Kopp, J. B., Poncelet, A. C., Hubchak, S. C., Stetler-Stevenson, W. G., Klotman, P. E., and Kleinman, H. K., Increased expression of extracellular matrix proteins and decreased expression of matrix proteases after serial passage of glomerular mesangial cells. J. Cell. Sci., 109, 2521-2528 (1996).
5. Cameron, J. S., Proteinuria and progression in human glomerular diseases. Am. J. Nephrol., 10 (Suppl 1), 81-87 (1990).
6. Appel G. B. and Appel A. S., Lipid-lowering agents in proteinuric diseases. Am. J. Nephrol., 10 (Suppl 1), 110-115 (1990).
7. Fujisawa, K., Yagasaki, K., Adachi, I., and Funabiki, R., Qualitative and quantitative effects of dietary proteins on hyperlipidemia and proteinuria in nephritic rats. Nutr. Res., 14, 1055-1066 (1994).
8. Fujisawa, K., Yagasaki, K., Miura, Y., and Funabiki, R., Improvement of hyperlipidemia and proteinuria without noticeable growth retardation by feeding a methionine and threonine supplemented low-casein diet to nephritic rats. Biosci. Biotechnol. Biochem., 59, 1896-1900 (1995).
9. Fujisawa, K., Yagasaki, K., Ishizuka, S., Miura, Y., and Funabiki, R., Reduction of renal transforming growth factor-beta activity without aggravation of growth retardation in nephritic rats by a methionine-threonine-supplemented low-casein diet. Biosci. Biotechnol. Biochem., 61, 230-232 (1997).
10. Narita, I., Border, W. A., Ketteler, M., and Ruoslahti, E., Noble, N.A., L-Arginine may mediate the therapeutic effects of low protein diets. Proc. Natl. Acad. Sci. USA, 92, 4522-4556 (1995).
11. Shibata, S., Miyakawa, Y., Naruse, T., Nagasawa, T., and Takuma, T., A glycoprotein that induces nephrotoxic antibody: its isolation and purification from rat glomerular basement membrane. J. Immunol., 102, 593-601 (1969).
12. Suzuki, Y., Nagamatsu, T., Kito, T., Kohmura, T., and Ito, M., Pharmacological studies on experimental nephritic rats (11). Changes in pathohistological and biochemical parameters in anti-rat GBM rabbit serum-induced nephritis. Folia. Pharmacol. Jpn., 77, 407-417 (1981).
13. Suzuki, Y., Tsukushi, Y., Ito, M., and Nagamatsu, T., Antinephritic effect of Y-19018, a thromboxane A synthetase inhibitor, on crescentic-type anti GBM nephritis in rats. Jpn. J. Pharmacol., 45, 177-185 (1987).
14. Yagasaki, K., Matsumoto, M., Fujisawa, K., Kuboya, A., and Funabiki, R., Effect of dietary lysine on endogenous hyperlipidemia in nephritic rats. Biosci. Biotechnol. Biochem., 56, 980-982 (1992).
15. Folch, J., Lees, M., and Sloane-Stanley, G. H., A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem., 226, 497-509 (1957).
16. Zak, B., Simple rapid microtechnic for serum total cholesterol. Am. J. Clin. Pathol., 27, 583-588 (1957).
17. Van Handel, E., Suggested modifications of the micro determination of triglycerides. Clin. Chem., 7, 249-251 (1961).
18. Chen, P. S., Toribara, T. Y., and Warner, H., Microdetermination of phospholipids. Anal. Chem., 28, 1756-1758 (1956).
19. Fujisawa, K., Yagasaki, K., and Funabiki, R., Reduction of hyperlipidemia and proteinuria without growth retardation in nephritic rats by a methionine-supplemented, low-soy-protein diet. Am. J. Clin. Nutr., 61, 603-606 (1995).
20. Bradford, M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254 (1976).
21. Duncan, D. B., Multiple range and multiple F tests. Biometrics, 11, 1-42 (1955).
22. Sado, Y., Kagawa, M., Kishiro, Y., Naito, I., Joh, K., and Ninomiya, Y., Purification and characterization of human nephritogenic antigen that induces anti-GBM nephritis in rats. J. Pathol., 182, 225-232 (1997).
23. Floege, J., Johnson, R. J., Gordon, K., Iida, H., Pritzl, P., Yoshimura, A., Campbell, C., Alpers, C. E., and Couser, W. G., Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int., 40, 477-488 (1991).
24. Schnaper, H. W., Balance between matrix synthesis and degradation: a determinant of glomerulosclerosis. Pediatr. Nephrol., 9, 104-111 (1995).
25. Atkins, R. C., Macrophages in renal injury. Am. J. Kidney Dis., 31, xlv-xlvii (1998).
26. Okuda, S., Languino, L. R., Ruoslahti, E., and Border, W. A., Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. J. Clin. Invest., 86, 453-462 (1990).
27. Ignotz, R. A., Endo, T., and Massague, J., Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-β. J. Biol. Chem., 262, 6443-6446 (1987).
28. Marti, H. P., Lee, L., Kashgarian, M., and Lovett, D. H., Transforming growth factor-beta 1 stimulates glomerular mesangial cell synthesis of the 72-kd type IV collagenase. Am. J. Pathol., 144, 82-94 (1994).
29. Okuda, S., Nakamura, T., Yamamoto, T., Ruoslahti, E., and Border, W.A., Dietary protein restriction rapidly reduces transforming growth factor β 1 expression in experimental glomerulonephritis. Proc. Natl. Acad. Sci. USA, 88, 9765-9769 (1991).
30. Forstermann, U. and Kleinert, H., Nitric oxide synthase: expression and expressional control of the three isoforms. Naunyn-Schmiedeberg's Arch. Pharmacol., 352, 351-364 (1995).
31. Cook, H. T. and Sullivan, R., Glomerular nitrite synthesis in in situ immune complex glomerulonephritis in the rat. Am. J. Pathol., 139, 1047-1052 (1991).
32. Cattel, V., Cook, T., and Moncada, S., Glomeruli synthesize nitrite in experimental nephrotoxic nephritis. Kidney Int., 38, 1056-1060 (1990).
33. Ikeda, M., Ikeda, U., Ohkawa, F., Shimada, K., and Kano, S., Nitric oxide synthesis in rat mesangial cells induced by cytokines. Cytokine, 6, 602-607 (1994).
34. Bremer, V., Tojo, A., Kimura, K., Hirata, Y., Goto, A., Nagamatsu, T., Suzuki, Y., and Omata, M., Role of nitric oxide in rat nephrotoxic nephritis: Comparison between inducible and constitutive nitric oxide synthase. J. Am. Soc. Nephrol., 8, 1712-1721 (1997).
35. Trachtman, H., Futterweit, S., and Singhal, P., Nitric oxide modulates the synthesis of extracellular matrix proteins in cultured rat mesangial cells. Biochem. Biophys. Res. Commun., 207, 120-125 (1995).
36. Jansen, A., Lewis, S., Cattel, V., and Cook, H. T., Arginase is a major pathway of L-arginine metabolism in nephritic glomeruli. Kidney Int., 42, 1107-1112 (1992).
37. Cook, H. T., Jansen, A., Lewis, S., Largen, P., O'donnell, M., Reaveley, D., and Cattell, V., Arginine metabolism in experimental glomerulonephritis: interaction between nitric oxide synthase and arginase. Am. J. Physiol., 267, F646-F653 (1994).
38. Peters, H., Border, W. A., and Noble, N. A., Tandem antifibrotic actions of L-agrinine supplementation and low protein diet during the repair phase of experimental glomerulonephritis. Kidney Int., 57, 992-1001 (2000).
39. Ferrario, R., Takahashi, K., Fogo, A., Badr, K. F., and Munger, K. A., Consequences of acute nitric oxide synthesis inhibition in experimental glomerulonephritis. J. Am. Soc. Nephrol., 4, 1847-1854 (1994).
40. G-monomethyl-L-arginine. J. Exp. Med., 179, 651-660 (1994).